Royal Philips has introduced the new HeartStart Intrepid monitor/defibrillator to assess and treat patients in medical emergencies across pre-hospital and hospital settings.

In hospitals, the device can be used by clinicians to evaluate a patient and provide the necessary intervention, including defibrillation in case of a sudden cardiac arrest.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Philips designed the HeartStart Intrepid monitor/defibrillator to be portable, lightweight and rugged for emergency medical service (EMS) use and transport within a hospital.

Vital patient monitoring parameters and diagnostic measurements from the device can accelerate triage and facilitate treatment decisions, added Philips.

The device comes with QCPR functionality that offers CPR feedback and guidance for compressions and ventilations.

It also has Traumatic Brain Injury (TBI) Advisory, which leverages vital sign evaluation to deliver the visual guidance required to avoid serious complications in people with suspected TBI.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

The device features the company’s IntelliSpace Connect data management solution, which enables loading of emergency event data into electronic patient care reporting (ePCR) and electronic medical records (EMR/EHR).

This process is intended to offer correct event documentation for billing and secure storage of data for post-event review aimed at improving quality.

IntelliSpace Connect is powered by the Philips HealthSuite Cloud platform and can be accessed via a browser. The data management solution is intended to offer a cost-effective option for hospitals.

Royal Philips Therapeutic Care business leader Arman Voskerchyan said: “A full range of monitoring capabilities and decision support tools let emergency staff quickly evaluate and treat patients in life-threatening situations.

“Enhanced connectivity between care settings helps to streamline communication and improve clinical workflow for caregivers, ultimately allowing them to provide patients with better care.”

Philips HeartStart Intrepid monitor/defibrillator has secured CE-Mark approval and is now commercially available in Europe and certain Asian and African markets.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
HemoSonics has won the 2025 Marketing Award for its impactful promotion of theQuantra Hemostasis System and leadership in blood management education. See how targeted campaigns, thought leadership content, and hands on clinician training are accelerating Quantra’s market traction and shaping the future of hemostasis testing.

Discover the Impact